ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - simvastatin, quantity: 10 mg - tablet, film coated - excipient ingredients: citric acid monohydrate; lactose monohydrate; titanium dioxide; ascorbic acid; hypromellose; purified talc; microcrystalline cellulose; iron oxide yellow; pregelatinised maize starch; iron oxide red; magnesium stearate; butylated hydroxyanisole - adjunct to diet for treatment of hypercholesterolaemia.prior to initiating therapy with noumed simvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. noumed simvastatin is indicated in patients at high risk of coronary heart disease (chd) (with or without hypercholesterolaemia) including patients with diabetes, history of stroke or other cerebrovascular disease, peripheral vessel disease, or with existing chd to reduce the risk of cardiovascular death, major cardiovascular events including stroke, and hospitalisation due to angina pectoris.these effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

scoliosis clinics australia pty ltd - 40761 - ultrasound system, imaging, general-purpose - scolioscan is a imaging modality for the assessment of spine deformity using a 3d ultrasound technique. it provides a coronal view of spine for the evaluation of severity of scoliosis. it is designed to use in hospital or clinics settings for scoliosis screening, diagnosis, curve progression monitoring, treatment outcome assessment, and scientific research. in addition, the system can facilitate spinal brace fitting for scoliosis patients.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

ego pharmaceuticals pty ltd - mometasone furoate, quantity: 1 mg/g - lotion - excipient ingredients: ethanol; citric acid; propylene glycol; hypromellose; purified water - for the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis.,zatamil lotion is suitable for use in scalp psoriaris and application to other areas of the body.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

clinics wa pty ltd - ascorbic acid,biotin,calcium citrate,calcium pantothenate,cysteine,equisetum arvense,folic acid,glutamine,glycine,histidine,iron amino acid chelate,lysine hydrochloride,manganese amino acid chelate,nicotinamide,pyridoxine -

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

clear-pak australia pty ltd - 11961 - shield, face - clear face shields to be used to protect eyes, nose, mouth from air born droplets when in close contact with another person. can be used in health care environments such as hospitals/clinics as well as any other industry or personal use for the protection of infectious disease. can be used as a single product only or attached to head band (separate product).a clear, transparent guard worn over the face to protect the healthcare worker from blood and other body fluid splashes while performing a clinical procedure

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

dukesea pty ltd pty ltd t/a planet lighting - 12276 - light, examination - the intended purpose of this device is that the led's used in this light are to be used for medical lighting applications, to illuminate the field of view where close examination and/or minor medical procedures are required. e.g intensive care, recovery room, emergency facilities, general medical clinics etc.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

ellex medical pty ltd - 11389 - ultrasound system, imaging, ophthalmic - this device is a diagnostic ophthalmic ultrasound instrument specifically designed to be used by ophthalmologists, sonographers or trained echographers in clinics or outpatient facilities in a hospital or surgery for imaging and diagnosis of ocular structures and pathologies. it is assumed that the operator is trained in the operation of the instrument and on the medical interpretation of ultrasonic images. the patient is unable to influence the operation of the device. this device is used for ophthalmic imaging when the following conditions are present or suspected: . cataracts; . retinal detachments (a separation of the retina from the middle coat of the eyeball); . orbital lesions; . tumours; . foreign bodies; . inflammation; . vascular irregularities.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - follitropin delta, quantity: 72 microgram - injection, solution - excipient ingredients: phenol; methionine; sodium sulfate decahydrate; dibasic sodium phosphate dodecahydrate; polysorbate 20; phosphoric acid; sodium hydroxide; water for injections - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - follitropin delta, quantity: 36 microgram - injection, solution - excipient ingredients: phenol; methionine; sodium sulfate decahydrate; dibasic sodium phosphate dodecahydrate; polysorbate 20; phosphoric acid; sodium hydroxide; water for injections - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - follitropin delta, quantity: 12 microgram - injection, solution - excipient ingredients: phenol; methionine; sodium sulfate decahydrate; dibasic sodium phosphate dodecahydrate; polysorbate 20; phosphoric acid; sodium hydroxide; water for injections - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle.